Beeline Holdings, Inc. current report, 20 November 2018

Business Context and Reporting Period

This Form 8-K was filed by Eastside Distilling, Inc. (Nasdaq: EAST, EASTW) on November 21, 2018, reporting events occurring on November 20, 2018. The filing details the entry into a material definitive agreement for an underwritten public offering of common stock.

Key Financial Metrics and Transaction Details

  • Offering Size: 1,235,000 shares of common stock at a public offering price of $6.50 per share.
  • Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 185,250 shares.
  • Expected Net Proceeds: Approximately $7.2 million, or approximately $8.3 million if the over-allotment option is exercised in full (after deducting underwriting discounts and expenses).
  • Advisory Fee: 1% of gross proceeds payable to the representative.
  • Underwriter Warrant: A five-year warrant issued to the representative to purchase 5% of the shares sold in the offering at an exercise price of $7.80 per share.

Material Changes

The primary material change is the execution of the Underwriting Agreement with Roth Capital Partners, LLC. This transaction represents a significant capital raise event. The filing does not provide comparative financial data (revenue, profit, or cash flow) for prior periods as this is a current report regarding a specific transaction rather than a periodic financial statement.

Outlook, Risks, and Contingencies

  • Closing Date: Expected on or about November 23, 2018, subject to customary closing conditions.
  • Regulatory Framework: Shares and warrants are sold pursuant to a shelf registration statement effective August 29, 2018.
  • Restrictions: The Underwriter Warrant and shares issuable upon exercise are subject to transfer restrictions under FINRA rules.
  • Indemnification: Eastside has agreed to indemnify underwriters against certain liabilities under the Securities Act of 1933.

Investor Verification Checklist

  • Verify the final closing date and actual net proceeds received.
  • Confirm whether the underwriters exercised the 30-day over-allotment option.
  • Review the attached Underwriting Agreement (Exhibit 1.1) for specific covenants and termination provisions.
  • Monitor the impact of the new share issuance on existing shareholder dilution.
  • Check subsequent filings for the use of proceeds as disclosed in the prospectus supplement.